Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer.
Yildiz R, Benekli M, Ozkan M, Alkis N, Berk V, Kaplan MA, Ciltas A, Karaca H, Durnali AG, Coskun U, Dikilitas M, Sevinc A, Dane F, Yetisyigit T, Dogu GG, Buyukberber S. Yildiz R, et al. Among authors: dikilitas m. J Cancer Res Clin Oncol. 2012 Nov;138(11):1845-52. doi: 10.1007/s00432-012-1264-5. Epub 2012 Jun 22. J Cancer Res Clin Oncol. 2012. PMID: 22722713
Intestinal perforation after regorafenib usage.
Sarıcı B, Karakaş S, Uylas U, Aktaş A, Dikilitaş M, Kayaalp C. Sarıcı B, et al. Among authors: dikilitas m. Turk J Gastroenterol. 2018 Mar;29(2):245-247. doi: 10.5152/tjg.2018.17316. Turk J Gastroenterol. 2018. PMID: 29749339 Free PMC article. No abstract available.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page